Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 420.00
Bid: 410.00
Ask: 430.00
Change: -8.00 (-1.87%)
Spread: 20.00 (4.878%)
Open: 427.50
High: 427.50
Low: 420.00
Prev. Close: 428.00
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Supply&distribution agreement - Basan Germany GmbH

9 Jul 2012 07:00

RNS Number : 1575H
Tristel PLC
09 July 2012
 



 

 

 

TRISTEL plc

("Tristel" or "the Company")

 

Supply & distribution agreement - Basan Germany GmbH

 

Tristel plc, the manufacturer of infection prevention, contamination control and specialist hygiene products, announces its first major shipment of sterile-packed disinfectant products to Basan Germany GmbH ("Basan"). The shipment provides Basan with its initial stocking inventory of Tristel disinfectant products for use in the clean rooms of pharmaceutical manufacturers, medical device manufacturers, life sciences and biotech companies. The products are marketed under the "Crystel" brand and are manufactured in Tristel's own clean room facility.

 

The supply and distribution agreement with Basan became effective on 1 April 2012 and covers many of the main markets in Continental Europe, including Germany, France, Italy and Benelux.

 

Basan is based in Germany and is part of VWR International, a global laboratory supply and distribution business with revenues of approximately $4.1 billion in 2011 and operations in 20 countries.

 

Paul Swinney, CEO of Tristel, commented, "We have been working closely with Basan whilst we have been planning, constructing and commissioning our clean room facility. This is now fully operational and has been audited by Basan and some of its key pharmaceutical manufacturing clients. This shipment of all the sterile-packed product lines in our Crystel range marks the end of a long process of mobilisation and the beginning of our thrust into the global pharmaceutical and biotechnology market. In Basan, we are in partnership with one of the world's leading suppliers to this marketplace."

 

 

For further information please contact:

 

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

Liz Dixon, Finance Director

Walbrook PR Ltd

Tel: 020 7933 8780

Paul McManus

Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com

finnCap

Tel: 020 7600 1658

Geoff Nash (Corporate Finance)

Charlotte Stranner (Corporate Finance)

Simon Starr (Corporate Broking)

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNSVRUOABRAR
Date   Source Headline
9th Aug 200612:00 pmRNSDirector/PDMR Shareholding
9th Aug 20067:00 amRNSAcquisition update
16th Jun 20063:39 pmRNSDirector/PDMR Shareholding
6th Jun 20067:01 amRNSAcquisition update
26th May 20068:56 amRNSDirector/PDMR Shareholding
25th May 20068:21 amRNSDirector/PDMR Shareholding
24th May 200611:10 amRNSDirector/PDMR Shareholding
23rd May 20067:03 amRNSAcquisition & Trading Update
13th Feb 20067:01 amRNSInterim Results
6th Feb 200611:10 amRNSNotice of Results
23rd Dec 200512:22 pmRNSGrant of Options
15th Nov 200511:36 amRNSAGM Statement
7th Oct 20057:00 amRNSDirector/PDMR Shareholding
5th Oct 20053:29 pmRNSNotice of AGM
4th Oct 20055:18 pmRNSDividend payment date
3rd Oct 20057:00 amRNSFinal Results
19th Sep 20054:08 pmRNSNotice of Results
4th Jul 20057:00 amRNSGrant of Patent

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.